Artificial wombs sound like something from a weird sci-fi film. Yet scientists are building them right now. This article breaks down everything you need to know about artificial wombs, from the labs doing the work to the big ethical questions no one fully agrees on.
Artificial Wombs: The Idea That Refused to Stay Fiction
Most people first heard about artificial wombs from movies or novels. Aldous Huxley imagined babies growing in glass bottles in his 1932 book, Brave New World. The Matrix showed humans raised in pods. For decades, this was pure imagination. Today, though, it is a real area of science with real funding and real results.
Scientists call this technology ectogenesis. The word comes from Greek. “Ecto” means outside, and “genesis” means birth. So ectogenesis literally means birth outside the body. Researchers are exploring two main types: partial and full.
Partial ectogenesis focuses on keeping premature babies alive outside the womb. It picks up where a natural pregnancy had to stop. Full ectogenesis, on the other hand, would grow a baby entirely outside any human body, from embryo to birth. We are much closer to the first type. The second is still a long way off.
The Breakthrough That Changed Everything
The biggest moment in artificial womb research came in 2017. A team at the Children’s Hospital of Philadelphia, also known as CHOP, published a landmark study in Nature Communications. They kept extremely premature lamb fetuses alive for four full weeks in a device they called the “Biobag.”
These lambs were at a stage of development equal to a human baby born at 22 to 24 weeks. That is considered the very edge of viability. Inside the Biobag, the lambs grew normally. Their lungs developed. Their brains developed. Their organs matured.
The system worked by mimicking what the natural womb does. It filled the bag with artificial amniotic fluid. It used the fetal heartbeat to pump blood through an external oxygenator. No mechanical ventilator was needed. Furthermore, the lambs were eventually weaned off the system and began breathing on their own.
This was not just impressive science. It was proof that extra-uterine fetal development is actually possible.
You can read the original study here: Partridge et al., Nature Communications, 2017
How the EXTEND System Works
After the Biobag success, the CHOP team kept building. Their next-generation device is called EXTEND. It stands for EXTra-uterine ENvironment for Newborn Development. The goal is to eventually offer this system to the most premature human babies.
EXTEND is a fluid-filled incubator. It closely copies the conditions inside a real womb. The system delivers nutrients and oxygen through a tube connected to the umbilical vessels. It also removes waste from the baby’s blood. Critically, the baby’s own heart does all the work of pumping blood.
This matters a lot. Mechanical ventilators, which are used in regular neonatal care, can seriously damage fragile premature lungs. EXTEND avoids that problem. It lets the lungs keep developing before they have to do any breathing.
Since 2017, researchers from many other countries have joined this effort. Teams in Spain, Japan, Australia, Singapore, the Netherlands, and the University of Michigan are all working on similar or competing systems. Scientific American covered this global effort in 2024.
Where Things Stand in 2026
As of 2026, no human baby has been placed inside an artificial womb. This is important to state clearly. The technology is not yet approved for use on humans. However, the steps toward that approval are moving forward.
The CHOP team has been in active discussions with the US Food and Drug Administration, the FDA, about running the first human clinical trials. In late 2023, the FDA held a special advisory panel meeting to discuss exactly this. Experts debated the science, the safety, and the ethics.
The panel did not give an immediate green light. There is still a lot of uncertainty. Transitioning from lamb studies to human babies is a massive leap. Lamb fetuses at a similar developmental stage are two to three times bigger than human premature babies. The equipment needs to be much smaller and much more precise.
Still, the first-in-human trials are now projected for sometime between 2026 and 2028. These would be highly controlled experiments. They would involve only a small number of infants born at the very edge of viability, around 22 to 24 weeks, for whom all other options have failed.
Read more about the 2026 regulatory status here.
Artificial Wombs and Premature Birth: A Real Need
Premature birth is one of the leading causes of infant death worldwide. Babies born before 28 weeks face enormous challenges. Their lungs are not ready to breathe. Their brains are fragile. Their immune systems are underdeveloped.
Current neonatal intensive care units, or NICUs, do heroic work. However, they have real limitations. Mechanical ventilation can cause chronic lung disease. The survival rate for babies born at 22 weeks is still very low.
Artificial womb technology is not meant to replace pregnancy for healthy mothers. Instead, it aims to give these extremely premature babies a better chance. It would essentially pause the developmental clock so the baby can keep growing in a safe, womb-like environment.
A 2026 systematic review published through PubMed looked at all the animal evidence gathered so far. The review confirmed that results in large animals are promising. At the same time, it highlighted the significant gaps still remaining before human use is safe and ethical.
The Bigger Vision: Full Ectogenesis
While partial ectogenesis focuses on premature babies, some researchers dream bigger. Full ectogenesis would allow a baby to grow entirely outside the body, from the very start of pregnancy to delivery.
For some people, this sounds amazing. It could help those who cannot carry a pregnancy due to medical reasons. It could allow same-sex male couples to have biological children without a surrogate. It could also, theoretically, eliminate the physical risks of pregnancy altogether.
However, full ectogenesis remains far in the future. The technical barriers are enormous. A natural womb does not just hold a fetus. It sends complex hormonal signals. It adjusts in real time. It creates a sensory and emotional environment that scientists do not yet fully understand.
As of 2024 and 2025, no prototype for full ectogenesis exists beyond theoretical models. Even the most optimistic timelines place full ectogenesis decades away. Partial ectogenesis for premature babies is the realistic near-term goal.
The Ethics Are Complicated, to Put It Nicely
Science moves fast. Ethics, law, and society often move slower. Artificial womb technology is already raising debates that have no easy answers.
Does it affect abortion rights?
This is one of the most heated discussions around artificial wombs. Some argue that if a fetus can survive outside the womb at a very early stage, this could change the legal definition of viability. That, in turn, could affect abortion access.
A 2025 review in the Journal of Ethics and Emerging Technologies looked at this question carefully. The review found that some scholars believe artificial womb technology could be used to argue against abortion, while others say reproductive rights should not depend on what technology exists. The debate is ongoing and deeply sensitive.
Who controls the process?
If a baby is growing in a machine, who makes medical decisions? The biological parents? The hospital? The state? These questions do not have clear legal answers yet. Legal scholars are already worried about the gaps.
Could it increase inequality?
Advanced medical technology tends to be expensive at first. If artificial womb access is limited to wealthy families or wealthy countries, it could worsen existing healthcare inequalities. A Wikipedia overview of the technology notes that implementing artificial wombs would require advanced infrastructure and significant costs. Source: Wikipedia on Artificial Womb
Feminist perspectives
Some feminist scholars welcome the idea. They argue that full ectogenesis could free women from the physical burdens of pregnancy and make gender more equal in the reproductive process. Others, however, worry it could be used to pressure women into handing over pregnancies to machines. A Nature journal article from 2026 explored these tensions in depth. Read the ethics scoping review here.
What Researchers Are Saying
Scientists working in this field are careful to manage expectations. The technology is promising, but no one is claiming it is ready.
A philosophy professor at Santa Clara University, Susan Kennedy, wrote about the need to think carefully about gestational rights. She argues that the right to gestate should be respected alongside the right not to gestate. Her work is discussed here.
Meanwhile, Eduard Gratacós, a fetal medicine specialist at the University of Barcelona, has said that if clinical trials go well, the world will need multiple versions of these systems working in parallel. International collaboration, therefore, will be essential.
The University of Michigan team and the CHOP team are taking slightly different technical approaches. Both, however, hope to reach the FDA approval stage within the next few years.
Artificial Wombs in Popular Culture vs. Reality
It is worth stepping back to note just how much our expectations of this technology are shaped by fiction. The Matrix pods and Brave New World hatcheries make people imagine dystopian baby factories. Reality, so far, looks very different.
The short-term goal is a medical device that saves the lives of the tiniest, most fragile premature babies. Think of it as a supercharged incubator, not a replacement for human pregnancy. Furthermore, the ethical oversight involved in developing this technology is extensive. Researchers are not operating in secret. They are working closely with regulatory bodies, ethicists, and the public.
That said, the long-term implications are genuinely complex. Societies will need to have honest conversations about how this technology should and should not be used.
A Timeline of Key Milestones
Looking at how we got here helps make sense of where things are going.
1932: Aldous Huxley publishes Brave New World, imagining artificial gestation as a dystopian tool of social control.
1970s: Scientists begin exploring extracorporeal support for premature fetuses in academic discussions.
2017: CHOP team publishes the Biobag study in Nature Communications. Lamb fetuses survive and develop for four weeks outside the womb. This becomes the foundational proof-of-concept for modern artificial womb technology.
2020 to 2024: Teams around the world refine techniques. Nutrient formulas improve. Umbilical vessel connection methods become more precise. Studies in non-human primates begin.
2023: The FDA convenes an advisory panel to discuss what first-in-human trials might look like. The panel raises scientific and ethical cautions.
2025: Multiple systematic reviews compile the animal study evidence. Research teams in Europe secure additional funding. The BCNatal group in Spain achieves 12 days of survival in fetal lambs.
2026: First-in-human trials are in advanced planning stages. No human baby has yet been placed in an artificial womb. Regulatory discussions continue.
2027 to 2028: This is when human clinical trials may realistically begin, depending on funding and regulatory approval.
How Artificial Womb Technology Actually Works, Step by Step
Understanding the process helps separate fact from science fiction. Let’s walk through how current artificial womb systems operate.
First, a baby is born prematurely, typically through a caesarean section. This is done quickly and carefully to avoid any trauma. The baby is then immediately transferred into the system while still in a fetal state.
Next, surgeons connect the umbilical vessels to an external oxygenator. This device takes over the job that the placenta would normally do. It removes carbon dioxide from the blood and delivers fresh oxygen in return. No breathing is required at this stage.
The baby floats in warm, sterile fluid that closely resembles natural amniotic fluid. This fluid does more than just cushion the baby. It supports lung development. It carries nutrients. It protects against infection. Researchers have spent years getting the exact composition right.
Throughout the process, the baby’s vital signs are monitored continuously. Temperature, heart rate, blood pressure, and oxygen levels are all tracked in real time. The system responds and adjusts as needed. Furthermore, the baby keeps developing just as it would inside a natural womb.
Finally, when the baby has matured enough to handle the outside world, the process of weaning begins. The fluid is gradually reduced. The baby starts to breathe on its own. Eventually, the connection to the oxygenator is removed entirely.
This process has worked well in animal studies. Making it work for premature human babies is the next challenge, and it is a big one.
Artificial Womb Research Around the World
The race to develop this technology is genuinely global. Several countries and institutions are each taking slightly different approaches.
United States: The CHOP team and Vitara Biomedical, a spinoff company that has raised over 100 million US dollars, are leading the charge. The University of Michigan is running a parallel effort with its own system design.
Spain: The BCNatal group at the University of Barcelona has achieved notable milestones. In June 2023, they reported keeping fetal lambs alive for 12 days with stable organ health. Their project received additional funding of 4.3 million euros for the 2023 to 2026 phase. Human trials are planned for around 2027 to 2028.
Australia: The University of Western Australia has contributed key refinements in nutrient delivery and umbilical vessel connection techniques.
Japan: Japanese researchers have been working on ex-vivo uterine support systems for several years. Their work on miniaturization is particularly relevant given how small extremely premature human babies are.
Netherlands and Singapore: Teams in both countries are contributing to safety validation and bioengineering improvements.
This global spread of research is actually a good sign. It means no single group is rushing ahead without oversight. Instead, results are being shared, challenged, and validated across multiple independent teams.
Premature Birth by the Numbers
To understand why this research matters so much, it helps to look at the scale of the problem it is trying to solve.
According to global health data, around 15 million babies are born prematurely every year. That is roughly one in every ten births worldwide. Complications from premature birth are the leading cause of death in children under the age of five.
Babies born before 28 weeks of gestation are considered extremely premature. Their survival rates have improved dramatically over the past few decades thanks to advances in neonatal intensive care. However, improvement has slowed. There is a biological floor below which current technology struggles to go.
Babies born at 22 weeks have roughly a 10 to 20 percent survival rate at the best-equipped hospitals. Even those who survive often face serious long-term health challenges. These include chronic lung disease, vision and hearing problems, and neurological delays.
Artificial womb technology is being designed specifically to help this group. The goal is not to lower the gestational age of viability for its own sake. The goal is to give babies who are already born too early a better chance of surviving and thriving.
Artificial Wombs and the Future of Neonatal Care
Even the partial version of this technology could change neonatal medicine significantly. Today, babies born at 22 to 23 weeks have very poor survival rates. Many who survive face long-term health challenges, including chronic lung disease, neurological problems, and developmental delays.
Artificial womb technology, if it works in humans the way it works in animals, could dramatically improve outcomes for this group. Babies could be transferred from a struggling natural womb directly into an artificial womb. There, they could continue developing in a controlled, safe environment until they are stable enough to survive on their own.
This would not eliminate all risks. But it could move the needle significantly. Given that premature birth affects around 15 million babies every year worldwide, even modest improvements in survival rates would have a massive global impact.
The Road Ahead
Artificial wombs are not coming to hospitals next year. However, they are no longer a fantasy either. The science has crossed a critical threshold. We have proof it works in animals. We have regulatory bodies taking it seriously. We have multiple research teams competing and collaborating globally.
The next five to ten years will be defining. First-in-human trials will tell us whether what works in lambs also works in babies. The results of those trials will shape both the science and the policy debates for decades.
Beyond the immediate medical application, this technology forces humanity to think carefully about what birth means, who controls reproduction, and how far science should go. These are not easy questions. They deserve thoughtful, ongoing conversations across medicine, law, ethics, and society.
Artificial wombs may not be here yet. However, they are coming. And whether we welcome that fact, fear it, or feel both at the same time, it is better to understand it clearly than to be caught off guard.
What Doctors and Families Need to Know
If you are a parent, a person who is pregnant, or someone thinking about starting a family, you might be wondering what any of this means for you right now. The short answer is: not much, yet.
Artificial womb technology is still in the research phase. No hospital offers it as a clinical option. No doctor can prescribe it. At this stage, it is not a choice that families will be making anytime soon.
However, the trajectory is clear. Within the next decade, decisions about this technology will start to enter the real world of medicine. Doctors will need training. Hospitals will need protocols. Insurance systems will need to decide whether to cover it.
For parents of extremely premature babies, this technology represents hope. For anyone thinking about the broader implications for reproductive health, it raises questions that deserve serious thought.
The best thing anyone can do right now is stay informed. Follow developments from credible medical sources. Engage with the ethical debates. And resist the urge to panic based on headlines that sensationalize what is, at its core, a careful, incremental scientific effort.
Frequently Asked Questions About Artificial Wombs
Can a baby be grown completely in an artificial womb right now?
No. Current technology is aimed at supporting babies who are already born too early, not growing babies from conception. Full ectogenesis is decades away at the earliest.
Are artificial wombs safe?
They have shown safety in animal studies. Human safety data does not yet exist because no human trials have taken place. The first human trials, expected in the next few years, will specifically study safety as the primary goal.
Will artificial wombs replace natural pregnancy?
Extremely unlikely, at least in any near-term scenario. The technology is being developed as a medical tool for premature births. Even if full ectogenesis becomes possible eventually, natural pregnancy is unlikely to disappear. Most people, given the choice, would still opt for natural pregnancy.
Could artificial wombs end surrogacy?
Possibly, in the very long term. However, the technical barriers to full ectogenesis are so large that this is not an imminent concern. Surrogacy arrangements will remain the primary option for people who need gestational support for many years to come.
What happens to the baby’s development inside an artificial womb?
In animal studies, development has been normal across all measured markers: brain growth, lung maturation, organ development, and physical growth all progressed as expected. This is one of the most encouraging findings of the research so far.
Sources and Further Reading
- Partridge et al. (2017) – Original Biobag study: Nature Communications
- Scientific American – Human trials edge closer: scientificamerican.com
- Fertility Innovation Lab – 2026 status overview: fertilityinnovationlab.com
- Fertility Innovation Lab – Human gestation viability 2026: fertilityinnovationlab.com